Notably, the treatment-related death rate was 9%, occurring despite the use of reduced doses of steroids and lenalidomide as well as the administration of granulocyte- colony stimulating factor (G-CSF), and infection prophylaxis with acyclovir and sulfamethoxazole-trimethoprim. Here, CSF3 is linked to infection.